inositol - CISMeF

Preferred Label : inositol;

MeSH definition : An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.;

MeSH synonym : myoinositol; mesoinositol; chiro-inositol; chiro inositol;

MeSH Related Number : 6917-35-7 (Inositol);

Registry Number MeSH : 6917-35-7;

Wikipedia link : https://en.wikipedia.org/wiki/Inositol;

Codes EINECS : 201-781-2;

Is substance : O;

UNII : 4L6452S749;

InChIKey : CDAISMWEOUEBRE-GPIVLXJGSA-N;

Details

Origin ID

D007294;

UMLS CUI

C0021547;

ATC code(s)
- inositol [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Myo-Inositol Measurement [NCIt concept]
Currated CISMeF NLP mapping
- Inositol [ICD-11 Extension code]
- Inositol [LOINC component]
- Inositol [ICHI extension code]
- Inositol [SMS substance]
- Inositol [NCIt concept]
- Inositol (substance) [SNOMED CT concept]
- Myo-inositol [FMA entity]
- inositol [SNOMED Notion]
- inositols [IUPAC Term]
- myo-Inositol [Substance BNPC]
Indexing information
- myo-inositol-binding protein, pseudomonas [MeSH Supplementary Concept]
Pharmacological action(s)
- vitamin B complex [MeSH Descriptor]
Record concept(s)
- inositol [MeSH concept]
Related MeSH Supplementary Concept(s)
- (1,4,7,10,13,16-hexaoxacyclooctadecane)potassium 2-O-benzoyl-1,3,5-O-methylidyne-myo-inositol 4,6-cyclophosphate trihydrate [MeSH Supplementary Concept]
- (18F)-1-deoxy-1-fluoro-scyllo-inositol [MeSH Supplementary Concept]
- (E)-1-methoxy-2-O-(p-coumaroyl)-myo-inositol [MeSH Supplementary Concept]
- 1,2,3,4,5,6-hexa-O-acetyl-myo-inositol [MeSH Supplementary Concept]
- 1,2-3,4-di-O-cyclohexylidene-myo-inositol [MeSH Supplementary Concept]
- 1,2-4,5-di-O-isopropylidene-allo-inositol [MeSH Supplementary Concept]
- 1,2-5,6-di-O-cyclohexylidene-myo-inositol [MeSH Supplementary Concept]
- 1,2-5,6-di-O-isopropylidene-myo-inositol [MeSH Supplementary Concept]
- 1,3,5-triamino-1,3,5-trideoxy-inositol [MeSH Supplementary Concept]
- 1,3,5-trideoxy-1,3,5-tris(dimethylamino)-cis-inositol [MeSH Supplementary Concept]
- 1,5,6-tri-O-benzylmyoinositol [MeSH Supplementary Concept]
- 1,6-di-O-feruloyl-myo-inositol [MeSH Supplementary Concept]
- 1-O-acetyl-2,3-5,6-di-O-isopropylideneinositol [MeSH Supplementary Concept]
- 1-O-octadecyl-2-O-(2-inositolylethyl)-glycero-3-phosphatidylcholine [MeSH Supplementary Concept]
- 1-inosityl-2-acetamido-2-deoxyglucopyranoside [MeSH Supplementary Concept]
- 1D-1,4-di-O-(O-acetylmandeloyl)-2,3-5,6-di-O-isopropylidene-myo-inositol [MeSH Supplementary Concept]
- 1D-3-deoxy-3-hydroxymethyl-myo-inositol [MeSH Supplementary Concept]
- 1L-6-hydroxymethyl-chiro-inositol 2(R)-2-O-methyl-3-O-octadecylcarbonate [MeSH Supplementary Concept]
- 1l-1,5-di-O-p-hydroxyphenylacetyl-chiro-inositol [MeSH Supplementary Concept]
- 2,3-4,5-bis-O-(tetraisopropyldisiloxane-1,3-diyl)inositol [MeSH Supplementary Concept]
- 2,3-O-cyclohexylidene-myo-inositol [MeSH Supplementary Concept]
- 2,4(6)-di-O-benzoyl-6(4)-O-((7,7-dimethyl-2-oxobicyclo(2.2.1)heptan-1-ylmethyl)sulfonyl)-myo-inositol 1,3,5-orthoacetate [MeSH Supplementary Concept]
- 2,4(6)-di-O-benzoyl-myo-inositol 1,3,5-orthoformate [MeSH Supplementary Concept]
- 2,4,5,6-tetra-O-benzyl-D-myo-inositol [MeSH Supplementary Concept]
- 2,5-di-O-benzylmyoinositol [MeSH Supplementary Concept]
- 2,6-di-O-benzylmyoinositol [MeSH Supplementary Concept]
- 2-deoxy-2-((18)F)fluoro-myo-inositol [MeSH Supplementary Concept]
- 2-deoxy-2-fluoro-scyllo-inositol-1-O-dodecylphosphonate [MeSH Supplementary Concept]
- 2-deoxy-2-fluoroinositol [MeSH Supplementary Concept]
- 2-deoxyinosose [MeSH Supplementary Concept]
- 3'-(1-chloroethyl)-2,3-dihydro-1H-imidazo(2,1-i)purine-4-ium-7-yl-3'-deoxy-1',5',6'-tri-O-(methylsulfonyl)-muco-inositol chloride [MeSH Supplementary Concept]
- 3,4,5,6-tetra-O-acetyl-1,2-di-O-(3-(4'-acetoxy-3'-methoxyphenyl)-2-propenoyl)myo-inositol [MeSH Supplementary Concept]
- 3,6-di-O-benzyl-1,2-O-isopropylideneinositol [MeSH Supplementary Concept]
- 3-azido-3-deoxy-myo-inositol [MeSH Supplementary Concept]
- 3-deoxy-3-C-(phosphonomethyl)inositol [MeSH Supplementary Concept]
- 3-deoxy-3-fluoroinositol [MeSH Supplementary Concept]
- 4''-epi-validamycin A [MeSH Supplementary Concept]
- 4,5,6-tri-O-p-hydroxyphenylacetyl-chiro-inositol [MeSH Supplementary Concept]
- 4,6-di-O-acetyl-2-O-tosyl-myo-inositol 1,3,5-orthobenzoate [MeSH Supplementary Concept]
- 4,6-di-O-acetyl-2-O-tosyl-myo-inositol 1,3,5-orthoformate [MeSH Supplementary Concept]
- 4,6-di-O-benzyl-myo-inositol [MeSH Supplementary Concept]
- 4-O-(4-vinylbenzyl)-myo-inositol 1,3,5-orthoformate [MeSH Supplementary Concept]
- 4-hydroxyphenylacetyl-3-D-chiro-inositol ester [MeSH Supplementary Concept]
- 5-O-methyl-myo-inositol [MeSH Supplementary Concept]
- 5-deoxy-5-fluoroinositol [MeSH Supplementary Concept]
- 5-deoxyinositol [MeSH Supplementary Concept]
- 5-epi-(6-(2)H2)valiolone [MeSH Supplementary Concept]
- 6-(ortho-nitroveratryl)-caged IP3 [MeSH Supplementary Concept]
- 6-O-acryloyl-2-O-benzoyl-myo-inositol 1,3,5,-orthoformate [MeSH Supplementary Concept]
- 6-O-benzoyl-1,2-4,5-di-O-isopropylidene-myo-inositol [MeSH Supplementary Concept]
- 6-bromoconduritol [MeSH Supplementary Concept]
- 6-deoxy-6-fluoroinositol [MeSH Supplementary Concept]
- Amino-Cerv [MeSH Supplementary Concept]
- D-chiro-inositol-galactosamine [MeSH Supplementary Concept]
- D-myo-inositol-1,2,4-trisphosphate [MeSH Supplementary Concept]
- D-myo-inositol-1,3,4-trisphosphate [MeSH Supplementary Concept]
- D-myo-inositol-2,3,6-trisphosphate [MeSH Supplementary Concept]
- FT500 Plus [MeSH Supplementary Concept]
- GlcNalpha1-6-myo-inositol-1-HPO4-sn-1, 2-dipalmitoylglycerol [MeSH Supplementary Concept]
- N-(2-hydroxycyclohexyl)valiolamine [MeSH Supplementary Concept]
- N-(4-nitrophenyl)validamine [MeSH Supplementary Concept]
- N-(4-nitrophenyl)valienamine [MeSH Supplementary Concept]
- VP 602L [MeSH Supplementary Concept]
- allo-quercitol [MeSH Supplementary Concept]
- angiokapsul [MeSH Supplementary Concept]
- bis-1,5-diphospho-myo-inositol tetrakisphosphate [MeSH Supplementary Concept]
- bromoconduritol-B-epoxide [MeSH Supplementary Concept]
- cancell [MeSH Supplementary Concept]
- cis-1,2,3,5-trans-4,6-inositol-2,3,6-triangelate [MeSH Supplementary Concept]
- clofibrate, inositol nicotinate drug combination [MeSH Supplementary Concept]
- cobofitin [MeSH Supplementary Concept]
- conduritol aziridine [MeSH Supplementary Concept]
- conduritol epoxide [MeSH Supplementary Concept]
- deoxyvalidamine [MeSH Supplementary Concept]
- discoside [MeSH Supplementary Concept]
- epi-inositol [MeSH Supplementary Concept]
- galactopyranosyl-(1-3)-1-O-methyl-1-inositol [MeSH Supplementary Concept]
- galactosylononitol [MeSH Supplementary Concept]
- glucosaminyl(1-6)inositol [MeSH Supplementary Concept]
- hexakis(trifluoroacetyl)inositol [MeSH Supplementary Concept]
- inositol 4,6-carbonate [MeSH Supplementary Concept]
- inositol 4-(hexadecyloxy)-3-methoxybutanephosphonate [MeSH Supplementary Concept]
- inositol hexasulfate [MeSH Supplementary Concept]
- inositol nicotinate, pholedrine sulfate, troxerutin drug combination [MeSH Supplementary Concept]
- inositol-1,2,3,5-tetra angelate [MeSH Supplementary Concept]
- inositol-glycan [MeSH Supplementary Concept]
- inosose [MeSH Supplementary Concept]
- laminitol [MeSH Supplementary Concept]
- magnesium chlorphenoxyisobutyrate, mesoinositol hexanicotinate drug combination [MeSH Supplementary Concept]
- methylinositol [MeSH Supplementary Concept]
- minosaminomycin [MeSH Supplementary Concept]
- mycothiol [MeSH Supplementary Concept]
- myo-inosamine [MeSH Supplementary Concept]
- myo-inositol 1,3,5-orthobutyrate [MeSH Supplementary Concept]
- nitrosigine [MeSH Supplementary Concept]
- phakan [MeSH Supplementary Concept]
- phosphatidyl-3-deoxy-3-aminoethyl-inositol [MeSH Supplementary Concept]
- pinitol [MeSH Supplementary Concept]
- plicosepalin A [MeSH Supplementary Concept]
- proheparum [MeSH Supplementary Concept]
- proto-quercitol [MeSH Supplementary Concept]
- quebrachitol [MeSH Supplementary Concept]
- rhizopine [MeSH Supplementary Concept]
- scyllitol [MeSH Supplementary Concept]
- talo-quercitol [MeSH Supplementary Concept]
- validamine [MeSH Supplementary Concept]
- validamycin A [MeSH Supplementary Concept]
- validamycins [MeSH Supplementary Concept]
- validoxylamine A [MeSH Supplementary Concept]
- validoxylamine B [MeSH Supplementary Concept]
- validoxylamine G [MeSH Supplementary Concept]
- valiolamine [MeSH Supplementary Concept]
- vascunicol [MeSH Supplementary Concept]
- vibo-quercitol [MeSH Supplementary Concept]
- voglibose [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing inositol (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
- Vitamin [UMLS semantic type]
UMLS correspondences (same concept)
- Inositol [ICD-11 Extension code]
- Inositol [LOINC component]
- Inositol [NCIt concept]
- Inositol (substance) [SNOMED CT concept]
- Myo-inositol [FMA entity]
- Product containing inositol (medicinal product) [SNOMED CT concept]
- inositol [ATC Code]
- inositol [SNOMED Notion]
- inositols [IUPAC Term]
- myo-Inositol [Substance BNPC]
Validated automatic mappings to BTNT
- inositol [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients